Enantioselective synthesis of epi-(+)-Sch 642305: Observation of an interesting diastereoselection during RCM

Article abstract of DOI:10.1016/j.tetlet.2005.07.152

In an approach towards the enantioselective total synthesis of the novel bioactive natural product Sch 642305, an unusual diastereoselection during the key RCM reaction, resulted in the synthesis of the 11-epi-isomer of Sch 642305.

Full text of DOI:10.1016/j.tetlet.2005.07.152

Tetrahedron
Letters
Tetrahedron Letters 46 (2005) 6633–6636
Enantioselective synthesis of epi-(+)-Sch 642305: observation
of an interesting diastereoselection during RCM
Goverdhan Mehta* and Harish M. Shinde
Department of Organic Chemistry, Indian Institute of Science, Bangalore 560 012, India
Received 19 June 2005; revised 20 July 2005; accepted 29 July 2005
Available online 15 August 2005
Abstract—In an approach towards the enantioselective total synthesis of the novel bioactive natural product Sch 642305, an unusual
diastereoselection during the key RCM reaction, resulted in the synthesis of the 11-epi-isomer of Sch 642305.
Ó 2005 Published by Elsevier Ltd.
As part of a screening program in search of bacterial
DNA primase (DnaG) inhibitors as potential new anti-
biotics, scientists at Schering-Plough recently reported
the isolation of a novel natural product Sch 642305 1
from the fermentation broth of the fungus Penicillium
verrcosum (culture ILF-16214).1 The inhibition of
E. Coli bacterial DNA primase enzyme by 1 with an
EC50 value of 70 lM, though modest, constitutes an
important lead towards developing new antibacterials.1,2
More recently and quite intriguingly, the presence of 1
has also been encountered in the isolates of the fungus
Septofusidium sp. by a group at Merck and shown to ex-
hibit inhibition of HIV-1 Tat-dependent transactivation
with an IC50 value of 1.00 lM.3 The structure and abso-
lute configuration of 1 was elucidated by X-ray diffrac-
tion studies1 on its p-bromobenzoate derivative. While
the unusual framework of 1, composed of a 4-hydroxy-
cyclohexenone moiety fused to a decalactone moiety and
the presence of four stereogenic centres makes it a
challenging synthetic objective, it is the unique and
broad-ranging1,3 biological activity profile of Sch
642305, which evokes special appeal towards a synthetic
foray.
OR
OH
4
13
O
O
3
2
5
12
14
Me
O
Me
7 O
1
6
11
8
OTBS
10
O
O
9
(+)- 1
7
O
CO2Et
OTBS
OTBS
5
6
H
O
H
O
H
H
TBSO
(+)- 4
O
3
Scheme 1. Retrosynthetic analysis of (+)-Sch 642305.
We have very recently accomplished4 the first total syn-
thesis of (+)-Sch 642305 1 following our second genera-
tion approach in which C8–C9 double bond formation
through a RCM reaction was the pivotal step to gener-
ate the decalactone moiety. On the other hand, in our
first generation approach to 1, retrosynthetically de-
picted in Scheme 1, we opted for the generation of the
decalactone moiety on a preformed cyclohexenone plat-
form through a RCM protocol involving the formation
of the C9–C10 double bond. During the implementation
of this approach (Scheme 1), we encountered an unex-
pected diastereoselection during the key RCM step
and this culminated in the synthesis of 11-epi-(+)-Sch
642305 2 rather than the natural product 1. This inter-
esting observation leading to the synthesis of (+)-2
forms the subject matter of this letter.
*
Corresponding author. Tel.: +91 8022932850; fax: +91 8023600936;
e-mail: gm@orgchem.iisc.ernet.in
0040-4039/$ - see front matter Ó 2005 Published by Elsevier Ltd.
doi:10.1016/j.tetlet.2005.07.152

6634
G. Mehta, H. M. Shinde / Tetrahedron Letters 46 (2005) 6633–6636
According to the retrosynthetic theme displayed in
Scheme 1, the previously described chiral synthon (+)-
4,4,5 conveniently prepared from the readily available
Diels–Alder adduct 3 of cyclopentadiene and p-benzo-
quinone, was to serve as our starting point. Stereocon-
trolled conjugate addition and retro-[4+2] reaction in
(+)-4 was expected to deliver 5 in which sequential a-
alkylation to 6 and transesterification to 7 was expected
to set up the key RCM reaction enroute to the natural
product.
In actuality, Cu(I) mediated addition of butenylmagne-
sium bromide to the chiral synthon (+)-4 proceeded
with good exo-face selectivity (15:1) to furnish (+)-8.6
Thermal activation in (+)-8 disengaged the cyclopenta-
diene fragment through a retro-Diels–Alder reaction
to deliver cyclohexenone (ꢀ)-5 (Scheme 2). Kinetically
controlled a-alkylation7 in (ꢀ)-5 proceeded with good
stereoselection to furnish (ꢀ)-9 with the desired stereo-
chemical orientation of the two side arms.6 Controlled
Luche reduction8 in (ꢀ)-9 furnished a readily separable
mixture of epimeric alcohols (ꢀ)-10 and (ꢀ)-11 (1.3:1),
Scheme 2.6 The lack of stereoselectivity in the reduction
of (ꢀ)-9 was not a major deterrent as the unwanted iso-
mer (ꢀ)-10 could be readily oxidized to the enone (ꢀ)-9
and recycled. The stereochemistry of the required
epimer (ꢀ)-11 was secured by its conversion to the
c-lactone 12 on exposure to titanium isopropoxide
(Scheme 3). TBS-deprotection in 12 led to hydroxy-lac-
tone 13 and further derivatization to the p-nitrobenzo-
ate 14 furnished crystals suitable for X-ray structure
determination9 and an ORTEP diagram is displayed
in Scheme 3.
Scheme 3. Reagents and conditions: (a) Ti(OiPr)4, EtOH, 80 °C, 2 h,
90%; (b) HF, pyridine, THF, rt, 12 h, 88%; (c) p-nitrobenzoyl chloride,
DIPEA, DMAP (0.1 equiv), rt, 7 h, 85%.
of titanium isopropoxide proceeded smoothly and
expectedly furnished a 1:1 diastereomeric mixture of
esters 16a,b, the projected precursor for the key
RCM reaction as per the retrosynthetic sequence
shown in Scheme 1. Since, the diastereomers 16a,b
were inseparable, they were as such subjected to the
RCM reaction using the GrubbsÕ first generation cata-
lyst 17.
The initial attempts to induce RCM in 16a,b with
GrubbsÕ catalyst11 were unsuccessful and attributing this
failure to the intervention by unproductive chelation
(see 18 and 19) by the evolving carbene species, as has
been observed previously,12 we decided to explore 17
and Ti(OiPr)4 as a binary catalyst system.11,12b
The free hydroxyl group in (ꢀ)-11 was protected as the
TBDPS derivative to give (+)-15,6 so that the two sili-
con protecting groups on the six-membered ring could
be easily chemo-differentiated (Scheme 4). Transesterifi-
cation10 in 15 with racemic 3-buten-2-ol in the presence
H
O
O
H
H
a
b
O
H
TBSO
TBSO
(+)- 4
TBS
(-)- 5
O
(+)- 8
c
OH
OH
O
d
e
CO2Et
CO2Et
CO2Et
+
OTBS
OTBS
OTBS
(-)- 11
(-)- 10
(-)- 9
Scheme 2. Reagents and conditions: (a) butenylmagnesium bromide, CuI, THF, 85% (a:b = 1:15); (b) Ph–O–Ph, 220 °C, 10 min, 80%; (c) LDA,
˚
BrCH2CO2Et, ꢀ78 °C, 60%; (d) NaBH4, CeCl3, MeOH, ꢀ50 °C, 80% (10:11 = 1.3:1); (e) PDC, 4 A MS, DCM, 1 h, 0 °C, 92%.

G. Mehta, H. M. Shinde / Tetrahedron Letters 46 (2005) 6633–6636
6635
identical with that of the natural product. The formula-
tion of 11-epi-Sch 642305 (+)-2 led us to surmise that
during the key RCM reaction on 16a,b, only the a-
methyl diastereomer 16a reacted and this diastereo-
selection led exclusively to the formation of (+)-20
(Scheme 4).
OTBDPS
L
PCy3
Ru
O
Ru L
Cl
Cl
O
Ph
OTBS
18
Me
Me
PCy3
17
OTBDPS
The sensitivity of the RCM reaction to substitution on
the participating alkene moieties, steric environment
in the vicinity of the alkenes and presence of ligating
groups among other factors have been noted before.12
However, the profound effect of the stereochemistry
of the vicinal substituent (methyl group) on the course
of the RCM reaction of 16a,b observed here is quite
unusual. We do not have a ready explanation for this
diastereoselection but steric interactions between the
b-methyl group of 16b and the b-oriented C6-alkene
arm might be a causative factor that destabilizes the
requisite alignment of the alkenes, thereby leaving the
a-methyl isomer 16a to undergo the RCM reaction to
furnish 20.
O
O
Ru
L
L
OTBS
19
Indeed, exposure of 16a,b to GrubbsÕ catalyst 17 in the
presence of Ti(OiPr)4 led to a single product (+)-20 in
modest yield and we were somewhat surprised to
observe that this reaction did not proceed to completion
and that only one of the diastereomers had undergone
the RCM reaction although at this stage it was not clear
as to which diastereomer had reacted. This finding was
complemented by the observation that recovered 16a,b
from this RCM reaction exhibited enrichment of the
unreacted diastereomer. When we attempted to perform
the RCM reaction under forcing conditions or for long-
er duration or with the GrubbsÕ second generation cata-
lyst,13 the results were disappointing and mired with
complications. However, unmindful of the exact C-11
methyl stereochemistry in 20 at this stage but drawing
solace from the fact that we were dealing with a single
diastereomer, we proceeded further. Regioselective
hydrogenation in (+)-20 was uneventful and led to
(+)-21 (Scheme 4). Chemoselective deprotection14 in
(+)-21 led to the allylic alcohol (+)-22, which was fur-
ther oxidized with PDC to the corresponding enone
and the TBDPS group was deprotected to furnish 2
and not the anticipated natural product 1.6 The spectral
characteristics of 2, though similar to that of 1, were not
In short, we have explored a RCM based enantio-
selective approach to the recently reported bioactive
natural product Sch 642305. This effort has culmi-
nated in the synthesis of (+)-11-epi-Sch 642305 through
an unusual diastereoselection during the RCM
protocols.
Acknowledgements
H.M.S. thanks CSIR for the award of a research fellow-
ship. X-ray data were collected at the CCD facility at
IISc. We thank Mr. Atsuya Hirano and Mr. Tan Naka-
gawa, Amano Enzyme Co., Nagoya, Japan, for their
generous gift of Lipase PS-D. This research was sup-
ported by the Chemical Biology Unit of JNCASR in
Bangalore.
OTBDPS
OTBDPS
OTBDPS
O
O
c
a
CO2Et
b
O
Me
(-)- 11
O
Me
OTBS
OTBS
OTBS
(+)- 15
(+)- 20
d
16a= α - Me
16b= β- Me
OH
OTBDPS
OTBDPS
O
O
O
e
f
O
Me
O
Me
O
Me
11
O
OH
OTBS
(+)-11- epi-Sch 642305
(+)- 22
(+)- 21
(+)- 2
Scheme 4. Reagents and conditions: (a) TBDPSCl, imidazole, DMF, rt, 12 h, 92%; (b) Ti(OiPr)4, 3-butene-2-ol, 90 °C, 10 h, 83%; (c) GrubbsÕ
catalyst 17 (20 mol %), Ti(OiPr)4, benzene, 80 °C, 2 h, 30%; (d) (Ph3P)3RhCl, H2(1 atm), 45 h, 77%; (e) PPTS, EtOH, 81%, 12 h (95% based on
˚
recovered starting material); (f) (i) PDC, 4 A MS, DCM, 5 h, 92%; (ii) TBAF, AcOH (1:1), THF, rt, 9 h, 91%.

6636
G. Mehta, H. M. Shinde / Tetrahedron Letters 46 (2005) 6633–6636
127.27, 67.83, 41.36, 27.01 (3C), 25.82 (3C), 20.91, 19.56,
References and notes
18.04, ꢀ3.83, ꢀ4.54; HRMS calcd for C36H52Si2O4 (M+
23
Na): 627.3302 found: 627.3315; (+)-22 ½aꢁD +150.0
1. Chu, M.; Mierzwa, R.; Xu, L.; He, L.; Terracciano, J.;
Patel, M.; Gullo, V.; Black, T.; Zhao, W.; Chan, T.;
Mcphail, A. T. J. Nat. Prod. 2003, 66, 1527.
(c 0.22, CHCl3); IR (neat) 3449, 2930, 2855, 1726 cmꢀ1
;
1H NMR (300 MHz, CDCl3): d 7.66 (t, J = 7.5 Hz, 4H),
7.45–7.34 (m, 6H), 5.62 (d, J = 9.6 Hz, 1H), 5.40 (dd,
J = 9.6 and 4.8 Hz, 1H), 5.05–4.95 (m, 1H), 4.07 (t,
J = 3.6 Hz, 1H), 3.91–3.86 (m, 1H), 2.63–2.56 (m, 1H),
2.12–2.05 (m, 3H), 1.97–1.79 (m, 2H), 1.67–1.45 (m, 7H),
1.27 (d, J = 6.6 Hz, 3H), 1.04 (s, 9 H); 13C NMR
(75 MHz, CDCl3): 175.44, 136.19, 135.89, 134.39, 133.72,
133.38, 129.89, 129.60, 129.38, 127.78, 127.31, 72.08,
71.20, 69.59, 41.86, 39.24, 31.57, 27.08 (3C), 24.79,
22.87, 19.56; HRMS calcd for C30H40SiO4 (M+Na):
´
2. (a) Bouche, J.-P.; Zechel, K.; Kornberg, A. J. Biol. Chem.
1975, 250, 5995; (b) Arai, K.-I.; Kornberg, A. Proc. Natl.
Acad. Sci. U.S.A. 1979, 76, 4308; (c) Richet, H.; Moham-
med, J.; McDonald, L. C.; Jarvis, W. R. Emerg. Infect.
Dis. 2001, 7, 319; (d) Grompe, M.; Versalovic, J.; Koeuth,
T.; Lupski, J. R. J. Bacterial. 1991, 173, 1268; (e)
Shrimankar, P.; Stordal, L.; Maurer, R. J. J. Bacterial.
1992, 174, 7689.
3. Jayasuriya, H.; Zink, D. L.; Polishook, J. D.; Bills, G. F.;
Dombrowski, A. W.; Genilloud, O.; Pelacz, F. F.;
Herranz, L.; Quamina, D.; Lingham, R. B.; Danzeizem,
R.; Graham, P. L.; Tomassini, J. E.; Singh, S. B. Chem.
Biodiversity 2005, 2, 112.
4. Mehta, G.; Shinde, H. M. Chem. Commun. 2005, 3703.
5. (a) Takano, S.; Higashi, Y.; Kamikubo, T.; Moriya, M.;
Ogaswara, K. Synthesis 1993, 948; (b) Konno, H.;
Ogaswara, K. Synthesis 1999, 1135; (c) Mehta, G.; Islam,
K. Synlett 2000, 1473.
24
515.2594 found: 515.2599; (+)-2 ½aꢁD +110.0 (c 0.4,
CH3OH); IR (neat) 3437, 2924, 2853, 1724, 1681 cmꢀ1
;
1H NMR (300 MHz, CDCl3): 6.97 (dd, J = 9.9 and
6.0 Hz, 1H), 5.94 (d, J = 9.9 Hz, 1H), 5.00–4.92 (m, 1H),
4.22 (dd, J = 6.0 and 3.3 Hz, 1H), 2.81 (dt, J = 12.3 and
3.9 Hz, 1H), 2.59–2.37 (m, 3H), 2.10–1.99 (m, 1H), 1.96–
1.77 (m, 2H), 1.72–1.41 (m, 4H), 1.28 (d, J = 6.0 Hz, 3H),
1.05 (m, 1H); 13C NMR (75 MHz, CDCl3): 202.54, 176.42,
148.49, 130.26, 74.41, 68.79, 47.78, 42.30, 40.03, 32.04,
25.76, 22.73, 22.25, 21.40; HRMS calcd for C14H20O4
(M+Na): 275.1259 found: 275.1265.
6. All new compounds were fully characterized on the basis
of IR, 1H NMR, 13C NMR and mass data. Spectral
26
7. Podraza, K. F.; Bassfield, R. L. J. Org. Chem. 1989, 54,
5919.
data of selected compounds: (+)-8 ½aꢁD ꢀ31.4 (c 1.4,
CHCl3); IR (neat) 2935, 2860, 1709 cmꢀ1 1H NMR
;
8. Gemal, A. L.; Luche, J. L. J. Am. Chem. Soc. 1981, 103,
5454.
(300 MHz, CDCl3): d 6.16 (dd, J = 5.4 and 3.3 Hz, 1H),
6.02 (dd, J = 5.4 and 3.3 Hz, 1H), 5.80–5.67 (m, 1H),
5.00–4.92 (m, 2H), 3.90 (m, 1H), 3.31 (br s, 1H), 3.12 (br s,
1H), 2.87–2.77 (m, 2H), 2.36–1.72 (m, 6H), 1.38–1.34 (m,
1H), 1.27–1.24 (m, 2H), 0.95 (s, 9H), 0.14 (s, 3H), 0.08 (s,
3H); 13C NMR (75 MHz, CDCl3): 212.61, 138.29, 136.98,
135.35, 114.59, 73.47, 51.98, 49.46, 47.20, 45.92, 44.80,
43.58, 36.55, 31.39, 30.50, 25.95 (3C), 18.12, ꢀ3.92, ꢀ4.87;
HRMS calcd for C21H34SiO2 (M+Na): 369.2226
9. Crystal data: X-ray data were collected at 293 K on a
SMART CCD–BRUKER diffractometer with graph-
˚
ite monochromated MoKa radiation (k = 0.7107 A). The
structure was solved by direct methods (SIR92). Refine-
ment was by full-matrix least-squares procedures on F2
using SHELXL-97. The non-hydrogen atoms were refined
anisotropically whereas the hydrogen atoms were placed
in geometrically idealised positions and constrained to ride
on their parent atoms. Compound (ꢀ)-14: C19H19NO6,
MW = 357, colourless crystal, crystal system: orthorhom-
bic, space group P212121: cell parameters: a = 4.8563(7)
25
found: 369.2213; (ꢀ)-9 ½aꢁD ꢀ109.7 (c 0.72, CHCl3); IR
1
(neat) 2930, 2858, 1735, 1686 cmꢀ1; H NMR (300 MHz,
CDCl3): d 6.78 (dd, J = 10.2 and 2.1 Hz, 1H), 5.95 (dd,
J = 10.2 and 2.1 Hz, 1H), 5.85–5.70 (m, 1H), 5.06–4.96
(m, 2H), 4.41–4.37 (m, 1H), 4.19–4.11 (m, 2H), 2.78–2.54
(m, 3H), 2.24–2.03 (m, 3H), 1.79–1.76 (m, 1H), 1.65–1.45
(m, 1H), 1.27 (t, J = 7.2 Hz, 3H), 0.92 (s, 9H), 0.15 (s,
3H), 0.13 (s, 3H); 13C NMR (75 MHz, CDCl3): 199.36,
172.24, 152.36, 137.77, 127.57, 115.02, 69.92, 60.60, 46.26,
45.83, 32.17, 27.47, 25.70 (3C), 17.93, 14.15, 9.18, ꢀ4.14,
ꢀ4.80; HRMS calcd for C20H34SiO4 (M+Na): 389.2124
˚
˚
˚
˚
A,
b = 15.617(2) A,
A , Z = 4, Dc = 1.32 g cmꢀ3
mmꢀ1
c = 23.622(4) A,
V = 1791.50
3
,
F(000) = 752, l = 0.10
.
Total number of ls parameters = 235, R1 =
0.0835 for 2558 Fo > 4sig(Fo) and 0.1066 for all 3159
data. wR2 = 0.1888, GOF = 1.155, Restrained GOF =
1.155 for all data. Crystallographic data (without structure
factors) have been deposited with the Cambridge Crystallo-
graphic Data Centre (CCDC 275655).
26
found: 389.2135; (ꢀ)-11 ½aꢁD ꢀ27.5 (c 1.2, CHCl3);
IR (neat) 3450, 2929, 2858, 1731.8 cmꢀ1 1H NMR
;
10. Seebach, D.; Hungerbuhler, E.; Naef, R.; Schnurrenber-
¨
ger, P.; Weidmann, B.; Zuger, M. Synthesis 1982, 138.
¨
(300 MHz, CDCl3): d 5.87–5.69 (m, 3H), 5.06–4.94 (m,
2H), 4.19–4.10 (m, 3H), 3.93 (d, J = 6.3 Hz, 1H), 2.67–
2.48 (m, 2H), 2.23–2.03 (m, 4H), 1.79–1.56 (m, 2H), 1.49–
1.37 (m, 1H), 1.26 (t, J = 7.2 Hz, 3H), 0.89 (s, 9H), 0.08 (s,
3H), 0.07 (s, 3H); 13C NMR (75 MHz, CDCl3): 174.30,
138.30, 132.83, 128.46, 114.68, 69.33, 65.28, 60.51, 41.22,
37.33, 33.90, 30.08, 28.07, 25.76 (3C), 17.94, 14.19, ꢀ4.17,
ꢀ4.79; HRMS calcd for C20H36SiO4 (M+Na): 391.2281
11. For recent reviews on RCM, see: (a) Grubbs, R. H.;
Chang, S. Tetrahedron 1998, 54, 4413; (b) Blechert, S.;
Schuster, M. Angew. Chem., Int. Ed. 1997, 36, 2036; (c)
Furstner, A. Angew. Chem., Int. Ed. 2000, 39, 3012; (d)
¨
Trnka, T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34, 18;
(e) Handbook of Metathesis; Grubbs, R. H., Ed.; Wiley-
VCH: Weinheim, Germany, 2003; Vol. 2.
23
12. (a) Ghosh, A. K.; Cappiello, J.; Shin, D. Tetrahedron
found: 391.2281; (+)-20 ½aꢁD +87.5 (c 0.4, CHCl3);
IR (neat) 2929, 2856, 1724 cmꢀ1 1H NMR (300 MHz,
;
Lett. 1998, 39, 4651; (b) Furstner, A.; Langemann, K.
¨
J. Am. Chem. Soc. 1997, 119, 9130; (c) Koskinen,
A. M. P.; Nevalainen, M. Angew. Chem., Int. Ed. 2001, 40,
4060.
CDCl3): d 7.72–7.66 (m, 4H), 7.47–7.34 (m, 6H), 5.74 (br s,
2H), 5.56 (d, J = 9.9 Hz, 1H), 5.40 (dd, J = 10.2 and
3.0 Hz, 1H), 5.34–5.30 (m, 1H), 4.10 (s, 1H), 3.85 (br s,
1H), 2.59–2.51 (m, 1H), 2.40–1.58 (m, 7H), 1.39 (d,
J = 6.3 Hz, 3H), 1.04 (s, 9 H), 0.94 (s, 9H), 0.08 (s, 6H);
13C NMR (75 MHz, CDCl3): 175.22, 136.14, 135.91,
134.38, 134.20, 133.36, 129.94, 129.85, 129.46, 127.76,
13. Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett.
1999, 1, 953.
14. Blair, I. A.; Saleh, S.; Prakash, C. Tetrahedron Lett. 1989,
30, 19.